|
| | HR0530 | | LRB101 14503 MST 63398 r |
|
|
1 | | HOUSE RESOLUTION
|
2 | | WHEREAS, Sarcoidosis is a non-contagious, systemic disease |
3 | | of unknown origin and is commonly diagnosed
with the detection |
4 | | of inflamed, microscopic growths, called granulomas, which |
5 | | most commonly
affect the lungs but can affect any organ in the |
6 | | body; many individuals stricken with sarcoidosis
eventually |
7 | | develop serious disabling conditions caused by damage to vital |
8 | | organs, such as eyes,
lungs, heart, brain, kidneys, and the |
9 | | central nervous system; and |
10 | | WHEREAS, Sarcoidosis is a disease that affects many of our |
11 | | fellow citizens and people around the world and
still remains a |
12 | | mystery; skin-related symptoms of this chronic, multi-system |
13 | | disease were
first recognized over 100 years ago, however, the |
14 | | effects of sarcoidosis on other bodily
organs were not observed |
15 | | until the first quarter of the 19th century; today, researchers |
16 | | are still
trying to learn more about the cause and the nature |
17 | | of this affliction; and
|
18 | | WHEREAS, Researchers believe sarcoidosis results from the |
19 | | inhalation of an infectious or allergic substance
from the |
20 | | environment, while others believe it is caused by an alteration |
21 | | of the body's cellular
immune system; and
|
22 | | WHEREAS, The National Sarcoidosis Society provides |